Forward Thinking Innovations

Forward Thinking Innovations (FTI) is a specialist respiratory medical device and drug delivery company based in the United Kingdom. The firm provides comprehensive design, development, and analytical services for inhalation products, including dry powder inhalers (DPIs) and pressurized metered-dose inhalers (pMDIs). Founded by a team of experts with extensive experience in the respiratory sector, FTI focuses on optimizing drug-device combinations to improve patient outcomes in conditions such as asthma and COPD. In December 2021, the company was acquired by Kindeva Drug Delivery, a global leader in drug-device combination products, to enhance Kindeva's internal R&D and device engineering capabilities. FTI's expertise spans the entire development lifecycle, from initial concept and feasibility to clinical supply and commercial manufacturing support.